1. VisualSonics VevoStrain Technology Provides Earlier Entry to
Left Ventricular Dysfunctions
A new dimension of diagnostic data:
Pressure analysis feature of Vevo 2100 high-frequency ultrasound technique allows highly
delicate and fast measurement of globe (whole heart) and regional (particular heart areas)
cardiac function.
TORONTO, Canada - April fourteen, 2011 - VisualSonics Inc., an innovator in real-time, in
vivo, large-resolution micro-imaging programs and a wholly-owned subsidiary of SonoSite
Inc., declared nowadays the purpose is VevoStraintechnologies have been featured on the
include with the April 15th, 2011 concern of Circulation Analysis, Journal with the American
Coronary heart Affiliation.
VevoStrain software gives superior imaging and quantification abilities to assess sensitive
actions inside of the coronary heart muscles - particularly the myocardium. The VevoStrain
technologies augments higher-resolution imaging capabilities of high-frequency ultrasound
with highly sensitive measurements of refined variations from the myocardium. The
VevoStrain software program allows tracking of wall motions in the coronary heart, this kind
of as complete heart and also described regions inside of heart. Measurement abilities
incorporate quantification of displacement, velocity, strain and strain price. Researchers at
Brigham and Women's Hospital, Harvard College of medicine current the utility of VevoStrain
technology as a non invasive, hugely delicate and quick cardiac phenotyping instrument
inside of their seminal paper on in vivo pressure investigation.
Dr Ronglih Liao, Associate Professor of medications, Harvard Healthcare Faculty mentioned,
We feel that, with strain evaluation, we now have a excellent and productive indicates for
non-invasively detecting early cardiac performance irregularities in mice. Even though
recognizing that this approach requires particular knowledge and knowledge to use, we have
been quite excited about potential customers for applying these analyses from now on
reports of experimental therapeutics.
The VevoStrain application plans are emerging as the manufacturer new state-of-the-artwork
evaluation tool for quantifying myocardial mechanical function and deformation, changing
Tissue Doppler imaging, which was utilized in yesteryear. Qualities in the application
incorporate measurement of cardiac wall movement abnormalities, dyssynchrony (delayed
ventricular activation and contraction) and myocardial mechanics. For more information, visit
here translational imagi
translational medicine